Top 10 Value Stocks To Own For 2019

tags:VNDA,FCNCA,LEN,CATB,VBLT,LIVE,LPTH,JAZZ,PTR,PLG,

5 Ways an AXA U.S. Spinoff Could Affect You

Distributions Out of a Cash Value Life Insurance Policy

Brokers May Run 2018 HealthCare.gov Group Enrollment

(Bloomberg) — The man tasked with shepherding Aflac Inc.’s $110 billion portfolio is ready to make a wager on private equity to generate more income for the insurer.

The firm plans to bet on alternatives including private equity later this year, according to Chief Investment Officer Eric Kirsch. That follows a move last month to invest in real estate undergoing change such as renovations or upgrades, and aligns with Kirsch’s goal to have at least 2.5% of the insurer’s cash invested in growth assets, such as public equities, private equity and real estate.

Copyright 2017 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

American Equity is cutting; Prudential wonders if it can; FBL wishes it could cut more.

Top 10 Value Stocks To Own For 2019: Vanda Pharmaceuticals Inc.(VNDA)

Advisors' Opinion:

• [By Stephan Byrd]

  Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $22.40.

Top 10 Value Stocks To Own For 2019: First Citizens BancShares, Inc.(FCNCA)

Advisors' Opinion:

• [By Max Byerly]

  American Century Companies Inc. reduced its holdings in First Citizens BancShares (NASDAQ:FCNCA) by 4.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,209 shares of the bank’s stock after selling 1,294 shares during the quarter. American Century Companies Inc. owned about 0.26% of First Citizens BancShares worth $12,897,000 at the end of the most recent quarter.

Top 10 Value Stocks To Own For 2019: Lennar Corp.(LEN)

Advisors' Opinion:

• [By ]

  In the Lightning Round, Cramer was bullish on T-Mobile US (TMUS) , Lennar (LEN) , Toll Brothers (TOL) , Tyson Foods (TSN) , JB Hunt Transport Services (JBHT) and International Paper (IP) .

• [By Chris Lange]

  The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Lennar Corp. (NYSE: LEN) which rose over 10% to $63.10. The stock��s 52-week range is $48.52 to $72.17. Volume was 18.5 million compared to the daily average volume of nearly 5 million.

• [By Peter Graham]

  A long term performance chart shows KB Home along with large caps D.R. Horton, Inc (NYSE: DHI), Lennar Corporation (NYSE: LEN) and PulteGroup, Inc (NYSE: PHM) somewhat all taking off once Donald Trump was sworn in:�

• [By JJ Kinahan]

  Next week is big for housing numbers. March existing home sales figures are scheduled for  Monday and new home sales for March along with the February S&P Case-Shiller Home Price Index on Tuesday. As for homebuilders, Pulte Group, Inc. (NYSE: PHM) is scheduled to report  Q1 results Tuesday, and D.R. Horton Inc (NYSE: DHI) is scheduled to report fiscal Q2 numbers on Thursday. The industry already has seen strong Q1 results from Lennar Corporation (NYSE: LEN), and housing starts and building permits in March rose more than expected. These results, as well as those and the economic data from next week could provide clues for the industry going forward. After NVR, Inc. (NYSE: NVR) reports results this morning, Meritage Homes Corp. (NYSE: MTH) releases its Q1 results April 25. We’ll have to wait until next month for some of the other homebuilders, as well as from home improvement companies Home Depot, Inc. (NYSE: HD) and Lowe’s Companies Inc (NYSE: LOW), before we get a more complete snapshot of the housing market.

Top 10 Value Stocks To Own For 2019: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors' Opinion:

• [By Max Byerly]

  These are some of the news articles that may have effected Accern’s analysis:

  Get Catabasis Pharmaceuticals alerts: Market Trends Toward New Normal in Church & Dwight Co., Rent-A-Center, Teradata, Catabasis Pharmaceuticals, Tronox, and Callaway Golf �� Emerging Consolidated Expectations, Analyst Ratings (finance.yahoo.com) Catabasis Pharmaceuticals Inc. – Receive News & Ratings Daily (thecasualsmart.com) Catabasis Pharmaceuticals (CATB) Upgraded by ValuEngine to Sell (americanbankingnews.com) Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10 (finance.yahoo.com) Catabasis Pharmaceuticals Inc (CATB) Given Consensus Rating of “Buy” by Brokerages (americanbankingnews.com)

  A number of analysts recently issued reports on CATB shares. Zacks Investment Research raised Catabasis Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Friday, January 26th. Wedbush reaffirmed an “outperform” rating and issued a $4.00 target price (down previously from $5.00) on shares of Catabasis Pharmaceuticals in a research report on Wednesday, February 14th. Finally, ValuEngine raised Catabasis Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 2nd. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Catabasis Pharmaceuticals presently has a consensus rating of “Buy” and a consensus target price of $5.18.

Top 10 Value Stocks To Own For 2019: Vascular Biogenics Ltd.(VBLT)

Advisors' Opinion:

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers ReTo Eco-Solutions, Inc. (NASDAQ: RETO) fell 9.3 percent to $4.50 in pre-market trading. ProPhase Labs, Inc. (NASDAQ: PRPH) shares fell 8.5 percent to $4.50 in pre-market trading after dropping 3.53 percent on Thursday. Nordstrom, Inc. (NYSE: JWN) fell 7.5 percent to $47.10 in pre-market trading. Nordstrom reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent. Baidu, Inc. (NASDAQ: BIDU) shares fell 6 percent to $263.00 in pre-market trading. Baidu disclosed that its COO Qi Lu will step down in July 2018. Riot Blockchain, Inc. (NASDAQ: RIOT) shares fell 5.6 percent to $8.98 in pre-market trading after climbing 11.88 percent on Thursday. Applied Materials, Inc. (NASDAQ: AMAT) fell 5 percent to $51.30 in pre-market trading. Applied Materials reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter. Blink Charging Co. (NASDAQ: BLNK) fell 5 percent to $7.61 in pre-market trading after rising 11.40 percent on Thursday. Illumina, Inc. (NASDAQ: ILMN) shares fell 4.7 percent to $255.77 in pre-market trading. Vascular Biogenics Ltd (NASDAQ: VBLT) fell 4.6 percent to $2.10 in pre-market trading after reporting a first-quarter earnings miss. Campbell Soup Company (NYSE: CPB) fell 3.3 percent to $37.60 in pre-market trading. Campbell Soup reported upbeat Q3 earnings, but sales missed estimates. The company also lowered its FY18 outlook. ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 2.7 percent to $17.65 in pre-market trading after reporting a 7.2 million common stock offering
• [By Lisa Levin] Companies Reporting Before The Bell Walmart Inc. (NYSE: WMT) is estimated to report quarterly earnings at $1.13 per share on revenue of $120.51 billion. J. C. Penney Company, Inc. (NYSE: JCP) is expected to report quarterly loss at $0.2 per share on revenue of $2.63 billion. Dillard's, Inc. (NYSE: DDS) is projected to report quarterly earnings at $2.77 per share on revenue of $1.46 billion. The Children's Place, Inc. (NASDAQ: PLCE) is estimated to report quarterly earnings at $2.21 per share on revenue of $444.14 million. Manchester United plc (NYSE: MANU) is expected to report quarterly loss at $1.35 per share on revenue of $193.67 million. Teekay Corporation (NYSE: TK) is estimated to report quarterly loss at $0.08 per share on revenue of $296.76 million. KEMET Corporation (NYSE: KEM) is projected to report quarterly earnings at $0.41 per share on revenue of $306.72 million. Vascular Biogenics Ltd. (NASDAQ: VBLT) is estimated to report a quarterly loss at $0.21 per share. Teekay Offshore Partners L.P. (NYSE: TOO) is expected to report quarterly earnings at $0.04 per share on revenue of $272.04 million. Albireo Pharma, Inc. (NASDAQ: ALBO) is expected to report quarterly earnings at $1.77 per share on revenue of $31.32 million.

   

Top 10 Value Stocks To Own For 2019: Live Ventures Incorporated(LIVE)

Advisors' Opinion:

• [By Ethan Ryder]

  Live Ventures (NASDAQ: LIVE) and PennantPark Investment (NASDAQ:PNNT) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Top 10 Value Stocks To Own For 2019: LightPath Technologies, Inc.(LPTH)

Advisors' Opinion:

• [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results. LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat. MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900. SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results. Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat. Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday. Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday. PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results. Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday. Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy. Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat. Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o

Top 10 Value Stocks To Own For 2019: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors' Opinion:

• [By Brian Feroldi, Keith Speights, and Sean Williams]

  So which biotechnology stocks do we think are smart buys right now? We asked these three Motley Fool investors -- all healthcare experts -- to weigh in, and they picked�Vertex Pharmaceuticals (NASDAQ:VRTX), Jazz Pharmaceuticals (NASDAQ:JAZZ), and�Neurocrine Biosciences (NASDAQ:NBIX).

• [By Keith Speights]

  But at least three of the biotechs singled out by the FDA deserve to be on another list -- investors' buy lists. Here's why Celgene (NASDAQ:CELG), Gilead Sciences (NASDAQ:GILD), and Jazz Pharmaceuticals (NASDAQ:JAZZ) look like great stock picks right now.

• [By Lisa Levin]

   

  Companies Reporting After The Bell Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion. Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion. The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion. Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million. Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion. LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion. Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion. TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million. The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million. A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion. Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million. Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million. ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million. KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13
• [By Max Byerly]

  Jazz Pharmaceuticals (NASDAQ:JAZZ) was downgraded by equities research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Friday.

• [By Lee Jackson]

  This top company is a favorite across Wall Street.�Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is a biopharmaceutical company that identifies, develops and commercializes pharmaceutical products for various medical needs in the United States, Europe and elsewhere. The company has a portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology.

Top 10 Value Stocks To Own For 2019: PetroChina Company Limited(PTR)

Advisors' Opinion:

• [By Max Byerly]

  ILLEGAL ACTIVITY NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect PetroChina (PTR) Stock Price” was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3368551/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-petrochina-ptr-stock-price.html.

• [By Lisa Levin] Gainers Shineco, Inc. (NASDAQ: TYHT) rose 34.7 percent to $2.29 in pre-market trading following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million. Carver Bancorp, Inc. (NASDAQ: CARV) rose 15.8 percent to $12.74 in pre-market trading after surging 201.37 percent on Thursday. LiveXLive Media, Inc. (NASDAQ: LIVX) shares rose 11.5 percent to $7.75 in pre-market trading after climbing 64.50 percent on Thursday. Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) rose 9 percent to $18.30 in pre-market trading after climbing 41.77 percent on Thursday. AmTrust Financial Services Inc (NASDAQ: AFSI) rose 6.2 percent to $14.25 in pre-market trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction. Cerner Corporation (NASDAQ: CERN) rose 5.6 percent to $64.02 in pre-market trading after the Department of Veterans Affairs reported an agreement with Cerner Government Services, Inc. to provide seamless care for veterans. PetroChina Company Limited (NYSE: PTR) shares rose 5.3 percent to $82.05 in pre-market trading. TC PipeLines, LP (NYSE: TCP) shares rose 5.2 percent to $26.59 in the pre-market trading session. IQVIA Holdings Inc. (NYSE: IQV) shares rose 4.8 percent to $102.50 in pre-market trading as the company pulled secondary offering 'in light of recent market conditions'. Axon Enterprise, Inc. (NASDAQ: AAXN) rose 4.5 percent to $59.70 in pre-market trading. On Thursday, Axon priced its 4.3 million share offering of common stock at $53 per share. The Trade Desk, Inc. (NASDAQ: TTD) rose 4.5 percent to $84 in pre-market trading. PetIQ Inc (NASDAQ: PETQ) rose 3.9 percent to $18.96 in pre-market trading after a 13G filing shows a new 5.05 percent stake by the State of New Jersey's Division of Investment. Mattel, Inc. (NASDAQ: MAT) shares rose 3.7 percent to $15.85 in pre-market

Top 10 Value Stocks To Own For 2019: Platinum Group Metals Ltd.(PLG)

Advisors' Opinion:

• [By Ethan Ryder]

  Shares of Platinum Group Metals (TSE:PTM) (NYSE:PLG) traded down 18.2% during mid-day trading on Friday . The stock traded as low as C$0.18 and last traded at C$0.18. 643,238 shares traded hands during mid-day trading, an increase of 400% from the average session volume of 128,626 shares. The stock had previously closed at C$0.22.